Does BRAF mutation status and related clinicopathological factors affect the recurrence rate of ameloblastoma? A systematic review, meta‐analysis and metaregression
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Does BRAF mutation status and related clinicopathological factors affect the recurrence rate of ameloblastoma? A systematic review, meta‐analysis and metaregression
Authors
Keywords
-
Journal
JOURNAL OF ORAL PATHOLOGY & MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-24
DOI
10.1111/jop.13494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adenoid ameloblastoma harbors beta-catenin mutations
- (2022) Victor Coutinho Bastos et al. MODERN PATHOLOGY
- Association of clinicopathological factors and treatment modalities in the recurrence of ameloblastoma: Analysis of 624 cases
- (2021) Yet Ching Goh et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors
- (2021) Bruna Pizziolo Coura et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessments
- (2020) Luke A. McGuinness et al. Research Synthesis Methods
- BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice
- (2020) Maria Sissa Pereira Sant’Ana et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Global incidence and profile of ameloblastoma: a systematic review and meta-analysis
- (2019) Faqi Nurdiansyah Hendra et al. ORAL DISEASES
- The importance of BRAF-V600E mutation to ameloblastoma metabolism
- (2019) Filipe Fideles Duarte-Andrade et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study
- (2019) S.W. Au et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts
- (2019) Ran Zhang et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Enabling Precision Medicine for Rare Head and Neck Tumors: The Example of BRAF/MEK Targeting in Patients With Metastatic Ameloblastoma
- (2019) Maxime Brunet et al. Frontiers in Oncology
- Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: A review
- (2018) Zhu You et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Radical vs conservative treatment of intraosseous ameloblastoma: systematic review and meta‐analysis
- (2018) Faqi Nurdiansyah Hendra et al. ORAL DISEASES
- Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis
- (2016) R. de A.C. Almeida et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- BRAFV600E mutation in the diagnosis of unicystic ameloblastoma
- (2016) Núbia Braga Pereira et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Regarding BRAF-inhibitor therapy of primary ameloblastoma
- (2016) Kelly R. Magliocca et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Recurrence rates of intraosseous ameloblastomas of the jaws: A systematic review of conservative versus aggressive treatment approaches and meta-analysis of non-randomized studies
- (2015) Georgios N. Antonoglou et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours
- (2015) Marina Gonçalves Diniz et al. TUMOR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now